Bioenhancers from mother nature and their applicability in modern medicine - PubMed (original) (raw)

Bioenhancers from mother nature and their applicability in modern medicine

Gurpreet Kaur Randhawa et al. Int J Appl Basic Med Res. 2011 Jan.

Abstract

Concept of bioenhancers or biopotentiators was first time reported in 1929 by Bose. A bioenhancer is an agent capable of enhancing bioavailability and efficacy of a drug with which it is co-administered, without any pharmacological activity of its own at therapeutic dose used. Development and consequent isolation of these molecules, such as piperine and quercetin, is considered as scientific breakthrough. A fixed drug combination (Risorine) of rifampicin, isoniazid, and piperine is the result of this research. It contains almost 60% less dose of rifampicin because of its increased bioavailability and it also prevents resistance. This concept is mentioned as yogvahi in ayurveda and was used to increase the effect of medicines by increasing oral bioavailability, decreasing adverse effects and to circumvent parenteral routes of drug administration. More such useful and economically viable drug combinations can be developed by integrating knowledge of time tested ayurveda with modern methods of research. This review is an account of these bioenhancers, available from the natural resources.

Keywords: Biopotentiators; piperine; yogvahi.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Similar articles

Cited by

References

    1. Varshneya C. Use of herbal bioenhancers in animal health care. [Last accessed on 2010 Nov 22]. Available from: http://www.hillagric.ernet.in/edu/covas/vpharma/winter%20school/lectures... .
    1. Sharma PV. Dravyaguna-Vijnana: Vegetable drugs. 2nd ed. Varanasi: Chaukhamba Bharati Academy; 2009. p. 109. (121,331-5,362-5).
    1. Pathak R. Ayurved Sar Sangrah. 12th ed. Kolkatta: Shri Baidyanath Ayurved Bhavan Limited; 2010. pp. 176–9. (212-24).
    1. Randhawa GK. Cow urine distillate as bioenhancer. J Ayur Integ Med. 2010;1:240–1. - PMC - PubMed
    1. Breedveld P, Beijnen JH, Schellens JH. Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs. Trends Pharmacol Sci. 2006;27:17–24. - PubMed

LinkOut - more resources